Gerd Kochendoerfer - 02 Jan 2025 Form 4 Insider Report for ATAI Life Sciences N.V. (ATAI)

Role
Chief Operating Officer
Signature
/s/ Ryan Barrett, Attorney-in-fact
Issuer symbol
ATAI
Transactions as of
02 Jan 2025
Net transactions value
$0
Form type
4
Filing time
03 Jan 2025, 16:30:23 UTC
Previous filing
13 Dec 2024
Next filing
03 Feb 2026
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction ATAI Stock Option Award $0 +1,450,000 $0.000000 1,450,000 02 Jan 2025 Common Shares 1,450,000 $1.60 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The stock option shall vest as to 25% on December 3, 2025 and in 36 substantially equal monthly installments thereafter.